CARE Ratings Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve alia to: (a) the Unaudited (Standalone ....
CARERATING · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
CARE Ratings has informed the stock exchanges that its Board of Directors will meet on November 12, 2025 to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2025 (Q2 FY26 / H1 FY26). The Board will also consider the declaration of an Interim Dividend, if any, for the financial year 2025-26. The trading window for dealing in the company's shares, which was closed from October 1, 2025, will remain closed until 48 hours after the results are declared, in line with insider trading regulations.
This is a routine pre-results intimation. Investors should watch the November 12 announcement for Q2 FY26 earnings details and any announcement on an interim dividend, which could influence short-term stock sentiment.